B G Solheim

Summary

Affiliation: Rikshospitalet University Hospital
Country: Norway

Publications

  1. ncbi Clinical implications of red blood cell and platelet storage lesions: an overview
    B G Solheim
    Institute of Immunology, Rikshospitalet University Hospital, NO 0027 Oslo, Norway
    Transfus Apher Sci 31:185-9. 2004
  2. ncbi Update on pathogen reduction technology for therapeutic plasma: an overview
    B G Solheim
    Institute of Immunology, Rikshospitalet Radiumhospitalet Medical Centre, University Hospital, University of Oslo, Oslo, Norway
    Transfus Apher Sci 35:83-90. 2006
  3. ncbi Rational use of blood products
    B G Solheim
    Institute of Immunology, Rikshospitalet, The National Hospital University of Oslo, NO 0027 Oslo, Norway
    Eur J Cancer 37:2421-5; discussion 2425-7. 2001
  4. ncbi Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection
    B G Solheim
    Institute of Immunology, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway
    Vox Sang 89:19-26. 2005
  5. ncbi Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood
    B G Solheim
    Institute of Immunology, Medical Department, Rikshospitalet University Hospital, NO 0027 Oslo, Norway
    Transfus Apher Sci 29:133-9. 2003
  6. ncbi Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood
    B G Solheim
    Red Cross and National Hospital Blood Centre, Oslo, Norway
    Vox Sang 74:168-75. 1998
  7. ncbi Survival of renal allografts from living donors and the importance of being the mother of the organ donor
    O Flesland
    Institute of Immunology, Rikshospitalet University Hospital, NO-0027 Oslo, Norway; Blood Bank, Asker and Baerum Hospital, Norway
    Transfus Apher Sci 32:13-5. 2005
  8. ncbi Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
    D Heldal
    Medical Department, Rikshospitalet University Hospital, 0027 Oslo, Norway
    Bone Marrow Transplant 29:479-86. 2002
  9. ncbi Viral safety of solvent/detergent-treated plasma
    B G Solheim
    Institute of Immunology, Rikshospitalet, The National Hospital, University of Oslo, Norway
    Transfusion 40:84-90. 2000
  10. ncbi The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story
    O Flesland
    Blood Bank, Baerum Hospital, N 1306 Barum, Norway
    Transfus Apher Sci 28:93-100. 2003

Collaborators

Detail Information

Publications12

  1. ncbi Clinical implications of red blood cell and platelet storage lesions: an overview
    B G Solheim
    Institute of Immunology, Rikshospitalet University Hospital, NO 0027 Oslo, Norway
    Transfus Apher Sci 31:185-9. 2004
    ..This overview highlights some laboratory and clinical aspects of red cell and platelet storage lesions...
  2. ncbi Update on pathogen reduction technology for therapeutic plasma: an overview
    B G Solheim
    Institute of Immunology, Rikshospitalet Radiumhospitalet Medical Centre, University Hospital, University of Oslo, Oslo, Norway
    Transfus Apher Sci 35:83-90. 2006
    ..These questions can only be answered by a head to head comparison, followed by large-scale clinical trials...
  3. ncbi Rational use of blood products
    B G Solheim
    Institute of Immunology, Rikshospitalet, The National Hospital University of Oslo, NO 0027 Oslo, Norway
    Eur J Cancer 37:2421-5; discussion 2425-7. 2001
    ..In this Update, we discuss current blood products, then suggest transfusion "triggers" in major surgery and haematological and oncologic practice. Finally, future developments and new possibilities are considered...
  4. ncbi Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection
    B G Solheim
    Institute of Immunology, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway
    Vox Sang 89:19-26. 2005
    ....
  5. ncbi Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood
    B G Solheim
    Institute of Immunology, Medical Department, Rikshospitalet University Hospital, NO 0027 Oslo, Norway
    Transfus Apher Sci 29:133-9. 2003
    ..Pre-storage leukocyte depletion thus improves the coagulation factor content of plasma in stored whole blood...
  6. ncbi Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood
    B G Solheim
    Red Cross and National Hospital Blood Centre, Oslo, Norway
    Vox Sang 74:168-75. 1998
    ..This study was to see whether the use of 0.5 CPD resulted in better preservation of FVIII and maintenance of 2,3-BPG...
  7. ncbi Survival of renal allografts from living donors and the importance of being the mother of the organ donor
    O Flesland
    Institute of Immunology, Rikshospitalet University Hospital, NO-0027 Oslo, Norway; Blood Bank, Asker and Baerum Hospital, Norway
    Transfus Apher Sci 32:13-5. 2005
  8. ncbi Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
    D Heldal
    Medical Department, Rikshospitalet University Hospital, 0027 Oslo, Norway
    Bone Marrow Transplant 29:479-86. 2002
    ..The short-term risks of BSC mobilisation and harvest seem negligible. The potential long-term effects of G-CSF are unresolved and the donors must be followed closely...
  9. ncbi Viral safety of solvent/detergent-treated plasma
    B G Solheim
    Institute of Immunology, Rikshospitalet, The National Hospital, University of Oslo, Norway
    Transfusion 40:84-90. 2000
    ..This method, however, does not affect non-lipid-enveloped viruses. The current study investigated the viral safety of SD-treated plasma (Octaplas) and paid particular attention to the transmission of non-lipid-enveloped viruses...
  10. ncbi The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story
    O Flesland
    Blood Bank, Baerum Hospital, N 1306 Barum, Norway
    Transfus Apher Sci 28:93-100. 2003
    ....
  11. ncbi Prevention and diagnosis of delayed haemolytic transfusion reactions
    C P Engelfriet
    Sanguin Research and Sanquin Diagnostic Services, Amsterdam, The Netherlands
    Vox Sang 91:353-68. 2006
  12. ncbi Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
    C A Akkok
    Department of Immunology and Transfusion Medicine, Ullevaal University Hospital, Kirkeveien 166, N 0407 Oslo, Norway
    Vox Sang 93:42-8. 2007
    ..5 days after monitoring each PC for bacterial contamination. In this prospective observational study, we compared apheresis PCs harvested by Amicus cell separator with buffy-coat (BC) PCs during storage for up to 6.5 days...